G M Peterson

Summary

Affiliation: University of Tasmania
Country: Australia

Publications

  1. ncbi Home medicines reviews following acute coronary syndrome: study protocol for a randomized controlled trial
    Daniel D L Bernal
    Unit for Medication Outcomes Research and Education UMORE, School of Pharmacy, University of Tasmania UTAS, Sandy Bay Campus, Tasmania 7001, Australia
    Trials 13:30. 2012
  2. ncbi A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study
    Leanne Stafford
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
    BMC Health Serv Res 11:16. 2011
  3. ncbi Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study
    Kevin P Mc Namara
    Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Centre for Medicine Use and Safety, 381 Royal Parade, Parkville, VIC 3052, Australia
    BMC Health Serv Res 10:264. 2010
  4. ncbi Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial
    Rosalind Lau
    Centre for Medicine Use and Safety, Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia
    BMC Health Serv Res 10:34. 2010
  5. ncbi Pharmacist's attitudes towards dispensing errors: their causes and prevention
    G M Peterson
    Tasmanian School of Pharmacy, Faculty of Health Science, University of Tasmania, Hobart, Australia
    J Clin Pharm Ther 24:57-71. 1999
  6. ncbi Selecting nonprescription analgesics
    Gregory M Peterson
    Tasmanian School of Pharmacy, Faculty of Health Science, University of Tasmania, Hobart, Tasmania 7001, Australia
    Am J Ther 12:67-79. 2005
  7. ncbi Valproate: a simple chemical with so much to offer
    G M Peterson
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Australia
    J Clin Pharm Ther 30:417-21. 2005
  8. ncbi Cardiovascular risk screening program in Australian community pharmacies
    Gregory M Peterson
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Locked Bag 26, Hobart, TAS, 7001, Australia
    Pharm World Sci 32:373-80. 2010
  9. ncbi Attitudes of Australian pharmacists towards practice-based research
    G M Peterson
    Unit for Medication Outcomes Research and Education, Tasmanian School of Pharmacy, University of Tasmania, Tasmania, Australia
    J Clin Pharm Ther 34:397-405. 2009
  10. ncbi Public perceptions of the role of Australian pharmacists in cardiovascular disease
    G M Peterson
    Unit for Medication Outcomes Research and Education, School of Pharmacy, Faculty of Health Science, University of Tasmania, Tasmania, Australia
    J Clin Pharm Ther 35:671-7. 2010

Collaborators

Detail Information

Publications57

  1. ncbi Home medicines reviews following acute coronary syndrome: study protocol for a randomized controlled trial
    Daniel D L Bernal
    Unit for Medication Outcomes Research and Education UMORE, School of Pharmacy, University of Tasmania UTAS, Sandy Bay Campus, Tasmania 7001, Australia
    Trials 13:30. 2012
    ..We have made two minor adjustments to target the focus of the existing service including an acute coronary syndrome specific referral letter and a training package for the pharmacists providing the service...
  2. ncbi A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study
    Leanne Stafford
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
    BMC Health Serv Res 11:16. 2011
    ..The current study aims to modify this previously trialled service model to implement and then evaluate a sustainable program to enable the smooth transition of patients taking warfarin from the hospital to community setting...
  3. ncbi Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study
    Kevin P Mc Namara
    Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Centre for Medicine Use and Safety, 381 Royal Parade, Parkville, VIC 3052, Australia
    BMC Health Serv Res 10:264. 2010
    ..It is therefore important to demonstrate the feasibility of multiple risk factor management by community pharmacists to ensure continued currency of their role...
  4. ncbi Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial
    Rosalind Lau
    Centre for Medicine Use and Safety, Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia
    BMC Health Serv Res 10:34. 2010
    ....
  5. ncbi Pharmacist's attitudes towards dispensing errors: their causes and prevention
    G M Peterson
    Tasmanian School of Pharmacy, Faculty of Health Science, University of Tasmania, Hobart, Australia
    J Clin Pharm Ther 24:57-71. 1999
    ..To assess the attitudes of pharmacists towards the issue of dispensing errors...
  6. ncbi Selecting nonprescription analgesics
    Gregory M Peterson
    Tasmanian School of Pharmacy, Faculty of Health Science, University of Tasmania, Hobart, Tasmania 7001, Australia
    Am J Ther 12:67-79. 2005
    ..Despite the possibility of hepatotoxicity in overdose, paracetamol represents a better all-round option for most patients requiring OTC analgesic therapy...
  7. ncbi Valproate: a simple chemical with so much to offer
    G M Peterson
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Australia
    J Clin Pharm Ther 30:417-21. 2005
  8. ncbi Cardiovascular risk screening program in Australian community pharmacies
    Gregory M Peterson
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Locked Bag 26, Hobart, TAS, 7001, Australia
    Pharm World Sci 32:373-80. 2010
    ....
  9. ncbi Attitudes of Australian pharmacists towards practice-based research
    G M Peterson
    Unit for Medication Outcomes Research and Education, Tasmanian School of Pharmacy, University of Tasmania, Tasmania, Australia
    J Clin Pharm Ther 34:397-405. 2009
    ..This included the canvassing of perceived barriers and potential solutions to promote research activity in pharmacy practice...
  10. ncbi Public perceptions of the role of Australian pharmacists in cardiovascular disease
    G M Peterson
    Unit for Medication Outcomes Research and Education, School of Pharmacy, Faculty of Health Science, University of Tasmania, Tasmania, Australia
    J Clin Pharm Ther 35:671-7. 2010
    ..To assess the public's perception of pharmacists' involvement and role in cardiovascular disease prevention and management...
  11. ncbi Harm minimization strategies: opinions of health professionals in rural and remote Australia
    G M Peterson
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Tasmania, Australia
    J Clin Pharm Ther 32:497-504. 2007
    ..This study was conducted to determine barriers to implementation, access to, and success of HM strategies, as seen by health professionals presently working in rural Australia...
  12. ncbi Educational campaign to improve the prevention of postoperative venous thromboembolism
    G M Peterson
    Tasmanian School of Pharmacy, Faculty of Health Science, University of Tasmania, Hobart, Australia
    J Clin Pharm Ther 24:279-87. 1999
    ..This project comprised a baseline assessment of the use of preventive measures within the Royal Hobart Hospital, followed by the implementation and evaluation of an educational program directed at hospital staff...
  13. ncbi Violence in community pharmacy in Australia: incidence and implications
    Gregory M Peterson
    School of Pharmacy, University of Tasmania, Hobart, TAS, 7001, Australia
    Int J Clin Pharm 33:264-72. 2011
    ..To estimate the frequency, nature and impact of violent incidents in Australian community pharmacies...
  14. ncbi Ipratropium treatment of acute airways disease
    Gregory M Peterson
    Tasmanian School of Pharmacy, Faculty of Health Science, University of Tasmania, Hobart, Australia
    Ann Pharmacother 37:339-44. 2003
    ..To examine the use of ipratropium bromide in adults with acute exacerbation of either asthma or chronic obstructive pulmonary disease (COPD) during admission and at discharge from 3 teaching hospitals...
  15. ncbi Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy
    G M Peterson
    School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
    J Clin Pharm Ther 29:23-30. 2004
    ..To evaluate a pharmacist-conducted educational and monitoring programme, designed to promote dietary and lifestyle modification and compliance with lipid-lowering drug therapy, for patients with dyslipidaemia...
  16. ncbi Lasofoxifene: selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis
    Gregory M Peterson
    School of Pharmacy, University of Tasmania, Tasmania, Australia
    Ann Pharmacother 45:499-509. 2011
    ..To review literature evaluating the pharmacology, pharmacokinetics, clinical efficacy, and adverse effects of lasofoxifene (CP-336156), a selective estrogen receptor modulator (SERM) that is not approved for use in the US...
  17. ncbi Improving the outcomes of anticoagulation in rural Australia: an evaluation of pharmacist-assisted monitoring of warfarin therapy
    S L Jackson
    School of Pharmacy, University of Tasmania, Hobart, TAS, Australia
    J Clin Pharm Ther 30:345-53. 2005
    ..Further research needs to be conducted on the impact of community pharmacy-conducted INR monitoring on patient care and outcomes...
  18. ncbi Improving the outcomes of anticoagulation: an evaluation of home follow-up of warfarin initiation
    S L Jackson
    School of Pharmacy, University of Tasmania, Tasmania, Australia
    J Intern Med 256:137-44. 2004
    ..01). CONCLUSIONS: This programme improved the initiation of warfarin therapy and resulted in a significant decrease in haemorrhagic complications in the first 3 months of therapy...
  19. ncbi Stroke risk assessment for atrial fibrillation: hospital-based stroke risk assessment and intervention program
    S L Jackson
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
    J Clin Pharm Ther 36:71-9. 2011
    ..The aim of this study was to implement and evaluate a system to improve the appropriate use of antithrombotics for stroke prevention in AF utilizing a clinical pharmacist as a stroke risk assessor...
  20. ncbi Warfarin management after discharge from hospital: a qualitative analysis
    L Stafford
    Unit for Medication Outcomes Research and Education UMORE, School of Pharmacy, University of Tasmania, Hobart, TAS, Australia
    J Clin Pharm Ther 37:410-4. 2012
    ....
  21. ncbi Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice
    S L Jackson
    Tasmanian School of Pharmacy, Faculty of Health Science, University of Tasmania, Hobart, Australia
    Intern Med J 31:329-36. 2001
    ..In clinical practice, warfarin confers a similar stroke risk reduction to that observed in trials, with an increase in incidence of only minor bleeding complications. Aspirin did not appear to reduce the risk of stroke...
  22. ncbi A methodological framework for estimating the clinical and economic value of community pharmacists' clinical interventions using expert opinion
    A C Stafford
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
    J Clin Pharm Ther 37:378-85. 2012
    ..This paper aimed to describe the complexities involved in estimating the clinical and economic outcomes of CIs performed by community pharmacists when using expert opinion and suggest avenues for improvement...
  23. ncbi Evaluation of repellent properties of volatile extracts from the Australian native plant Kunzea ambigua against Aedes aegypti (Diptera: Culcidae)
    J Thomas
    School of Pharmacy, University of Tasmania, Private Bag 26, Hobart, 7001 TAS, Australia
    J Med Entomol 46:1387-91. 2009
    ..ambigua oil. Both K. ambigua oil and citronella were significantly less repellent than deet. The K. ambigua essential oil formulations should not be advocated for use as repellents in regions prone to mosquito-borne disease...
  24. ncbi Point-of-care monitoring of anticoagulant therapy by rural community pharmacists: description of successful outcomes
    Shane L Jackson
    Tasmanian School of Pharmacy, University of Tasmania, Hobart, Tasmania 7001, Australia
    Aust J Rural Health 12:197-200. 2004
    ..Innovative service delivery models like these are needed to meet the needs of the increasing number of rural Australians requiring warfarin therapy...
  25. ncbi Pharmacist-provided quantitative heel ultrasound screening for rural women at risk of osteoporosis
    Mark Naunton
    Faculty of Health Science, Tasmanian School of Pharmacy, University of Tasmania, Tasmania, Australia
    Ann Pharmacother 40:38-44. 2006
    ..CONCLUSIONS: Pharmacist-provided screening for osteoporosis in rural areas is a potentially useful method to identify women at risk for fracture and a convenient time point for discussion of preventive therapy...
  26. ncbi Marketing of rural and remote pharmacy practice via the digital medium
    G M Peterson
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Australia
    J Clin Pharm Ther 35:409-14. 2010
    ..This DVD will complement current rural practical placements, which have been incorporated into the curriculum of Australian schools of pharmacy...
  27. ncbi Data-mining of medication records to improve asthma management
    Bonnie J Bereznicki
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, TAS, Australia
    Med J Aust 189:21-5. 2008
    ..To use community pharmacy medication records to identify patients whose asthma may not be well managed and then implement and evaluate a multidisciplinary educational intervention to improve asthma management...
  28. ncbi Pharmacist-initiated general practitioner referral of patients with suboptimal asthma management
    Bonnie J Bereznicki
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Tasmania, Australia
    Pharm World Sci 30:869-75. 2008
    ..Setting Community pharmacies throughout Tasmania, Australia...
  29. ncbi New antithrombotics for atrial fibrillation
    Luke R E Bereznicki
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Australia
    Cardiovasc Ther 28:278-86. 2010
    ..These new anticoagulants may well represent a new era in anticoagulation. However, they do possess their own limitations and will present new challenges for clinicians...
  30. ncbi Training Australian pharmacists for participation in a collaborative, home-based post-discharge warfarin management service
    Leanne Stafford
    Unit for Medication Outcomes Research and Education UMORE, School of Pharmacy, University of Tasmania, Private Bag 26, 7001, Hobart, Tasmania
    Pharm World Sci 32:637-42. 2010
    ..To describe the development, implementation and outcomes of an anticoagulation education program for pharmacists participating in a community-based post-discharge warfarin management service...
  31. ncbi Plasma glutathione peroxidase by ELISA and relationship to selenium level
    Glenn A Jacobson
    School of Pharmacy, University of Tasmania, Private Bag 26, Hobart, Tasmania 7001, Australia
    Clin Chim Acta 369:100-3. 2006
    ..Many assays have investigated GPx activity but there are few reports of immunoreactive methods of GPx plasma determinations and their relationship with plasma selenium...
  32. ncbi Drug-related problems identified in medication reviews by Australian pharmacists
    Andrew C Stafford
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Private Bag 26, Hobart, TAS 7001, Australia
    Pharm World Sci 31:216-23. 2009
    ..The objective of this study was to examine the number and nature of the drug-related problems identified and investigate differences between each type of review...
  33. ncbi Accuracy and clinical usefulness of the near-patient testing CoaguChek S international normalised ratio monitor in rural medical practice
    Shane L Jackson
    School of Pharmacy, University of Tasmania, Hobart, Tasmania
    Aust J Rural Health 12:137-42. 2004
    ..CONCLUSIONS: The routine use of near-patient testing, with appropriate training and quality assurance programs, has the potential to increase the safety and efficacy of warfarin therapy in rural and remote communities...
  34. ncbi Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring
    Luke R Bereznicki
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Australia
    J Clin Pathol 60:311-4. 2007
    ..To evaluate the accuracy of the CoaguChek XS international normalised ratio (INR) monitor compared with the laboratory method...
  35. ncbi Vitamin B12 deficiency in Australian residential aged care facilities
    C Mirkazemi
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Tasmania 7001, Australia
    J Nutr Health Aging 16:277-80. 2012
    ..To determine the prevalence of undiagnosed vitamin B12 deficiency among residential aged care facility residents in southern Tasmania, Australia, and to identify associated risk factors...
  36. ncbi The risks of warfarin use in the elderly
    Luke R Bereznicki
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
    Expert Opin Drug Saf 5:417-31. 2006
    ....
  37. ncbi Thromboprophylaxis following hip and knee arthroplasty
    C Mirkazemi
    School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
    Intern Med J 43:124-9. 2013
    ..To determine local thromboprophylaxis prescribing practices following arthroplasty...
  38. ncbi Development of an intelligent decision support system for medication review
    I K Bindoff
    School of Computing, University of Tasmania, Tasmania, Australia
    J Clin Pharm Ther 32:81-8. 2007
    ..This intelligent system could directly support pharmacists and other health professionals providing medication reviews...
  39. ncbi Toenail onychomycosis: an important global disease burden
    J Thomas
    School of Pharmacy, University of Tasmania, Tasmania Department of Podiatry, Royal Hobart Hospital, Hobart, Tasmania, Australia
    J Clin Pharm Ther 35:497-519. 2010
    ..In patient populations such as diabetic individuals, where onychomycosis can provoke lower extremity complications, professional podiatry care of toenails and feet should be encouraged...
  40. ncbi Undertreatment of congestive heart failure in an Australian setting
    P J Boyles
    Tasmanian School of Pharmacy, University of Tasmania, Tasmania, Australia
    J Clin Pharm Ther 29:15-22. 2004
    ..The relatively low use of drugs shown to improve survival in heart failure is of concern and warrants educational intervention...
  41. ncbi Randomised controlled trial of the treatment of pastern dermatitis with a formulation containing kunzea oil
    J Thomas
    School of Pharmacy, University of Tasmania, Hobart 7001, Tasmania, Australia
    Vet Rec 164:619-23. 2009
    ..The control formulation resulted in no significant change in the total area of the lesions, and the signs of pastern dermatitis resolved completely in only two of the 10 cases...
  42. ncbi Selenium status in Southern Tasmania
    G A Jacobson
    School of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia
    Eur J Clin Nutr 61:1057-63. 2007
    ..To assess the selenium status of Southern Tasmanians...
  43. ncbi A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation
    Shane L Jackson
    Tasmanian School of Pharmacy, University of Tasmania, Tasmania, Australia
    Ann Pharmacother 38:1794-9. 2004
    ..001). CONCLUSIONS: The educational program described here led to a significant increase in the prescribing of warfarin for stroke prevention in patients with AF...
  44. ncbi An electronic prompt in dispensing software to promote clinical interventions by community pharmacists: a randomized controlled trial
    James F Reeve
    Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Australia
    Br J Clin Pharmacol 65:377-85. 2008
    ..A markedly increased rate of recording and performing the targeted clinical intervention was found. The effect of the prompt reduces markedly once the prompt is deactivated...
  45. ncbi Psycholeptic use in aged care homes in Tasmania, Australia
    J L Westbury
    Unit for Medication Outcomes Research and Education UMORE, School of Pharmacy, University of Tasmania, Hobart, 7001 Tasmania, Australia
    J Clin Pharm Ther 35:189-93. 2010
    ..The aim of this study was to examine the current pattern of psycholeptic use in Tasmanian aged care homes and compare this data with other Australasian research...
  46. ncbi Accuracy, reproducibility and clinical utility of the CoaguChek S portable international normalized ratio monitor in an outpatient anticoagulation clinic
    S L Jackson
    School of Pharmacy, University of Tasmania, Tasmania, Australia
    Clin Lab Haematol 26:49-55. 2004
    ..The CoaguChek S displayed good correlation with laboratory determination of INR and compared relatively well with expanded and narrow clinical agreement criteria...
  47. ncbi Case-controlled review of Clostridium difficile-associated diarrhoea in southern Tasmania
    H A Halim
    Tasmanian School of Pharmacy, Faculty of Medicine and Pharmacy, University of Tasmania, Australia
    J Clin Pharm Ther 22:391-7. 1997
    ..Severely ill patients with compromised immune function are particularly susceptible, with antibiotic use being a major risk factor. Prompt diagnosis and initiation of treatment are important factors in the improvement of prognosis...
  48. ncbi Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis
    Mark Naunton
    Tasmanian School of Pharmacy and Menzies Research Institute, Faculty of Health Science, University of Tasmania, Tasmania, Australia
    J Rheumatol 31:550-6. 2004
    ..CONCLUSION: A multifaceted education program, incorporating academic detailing of general practitioners and community pharmacists, increased the use of osteoporosis prevention strategies in longterm oral corticosteroid users...
  49. ncbi Comment: increased sensitivity to warfarin after heart valve replacement
    Luke R Bereznicki
    Ann Pharmacother 40:1476-7. 2006
  50. ncbi Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR
    Shane L Jackson
    Am Heart J 149:e3; author reply e4. 2005
  51. ncbi Randomized trial of warfarin nomograms
    Gregory M Peterson
    Ann Intern Med 140:488; author reply 491-2. 2004
  52. ncbi Addressing information needs in the management of osteoporosis
    Mark Naunton
    Osteoporos Int 15:505; author reply 506. 2004
  53. ncbi Risk factors...but only after excluding high-risk subjects
    Gregory M Peterson
    Pharmacoepidemiol Drug Saf 13:253; author reply 255-6. 2004
  54. ncbi Practical utility of case-management telephone intervention in heart failure?
    Gregory M Peterson
    Arch Intern Med 162:2142-3; author reply 2143. 2002
  55. ncbi Comments on Glintborg et al.'s drug-drug interactions study (EJCP 2005; 61: 675-681)
    Mark Naunton
    Eur J Clin Pharmacol 62:159-60. 2006
  56. ncbi Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis
    Gregory M Peterson
    Obstet Gynecol 100:381; author reply 381-2. 2002
  57. ncbi The direct thrombin inhibitor melagatran/ximelagatran
    Luke R Bereznicki
    Med J Aust 182:254-5. 2005